5-Fluorouracil biomarkers in pancreatic neuroendocrine tumours

被引：0
|
作者：
de Mestier, Louis [1 ,2 ]
Cros, Jerome [2 ,3 ]
Hammel, Pascal [2 ,4 ]
机构：
[1] Beaujon Univ Hosp, AP HP, Dept Gastroenterol & Pancreatol, 100 Blvd Gen Leclerc, F-92110 Clichy, France
[2] Univ Paris 07, Clichy, France
[3] Beaujon Univ Hosp, AP HP, Dept Pathol, Clichy, France
[4] Beaujon Univ Hosp, AP HP, Dept Digest Oncol, Clichy, France
来源：
PANCREATOLOGY | 2017年 / 17卷 / 04期
关键词：
Chemotherapy; Neuroendocrine tumour; 5-Fluorouracil; Thymidylate synthase; Dihydropyrimidine-dehydrogenase; THYMIDYLATE-SYNTHASE; EXPRESSION; TEMOZOLOMIDE; CHEMOTHERAPY;
D O I：
10.1016/j.pan.2017.06.004
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：527 / 528
页数：2
相关论文
共 50 条
  • [1] Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy
    Lahner, Harald
    Mathew, Annie
    Klocker, Anna Lisa
    Unger, Nicole
    Theysohn, Jens
    Rekowski, Jan
    Joeckel, Karl-Heinz
    Theurer, Sarah
    Schmid, Kurt Werner
    Herrmann, Ken
    Fuehrer, Dagmar
    [J]. ENDOCRINE, 2022, 75 (01) : 293 - 302
  • [2] Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy
    Harald Lahner
    Annie Mathew
    Anna Lisa Klocker
    Nicole Unger
    Jens Theysohn
    Jan Rekowski
    Karl-Heinz Jöckel
    Sarah Theurer
    Kurt Werner Schmid
    Ken Herrmann
    Dagmar Führer
    [J]. Endocrine, 2022, 75 : 293 - 302
  • [3] Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
    Turner, N. C.
    Strauss, S. J.
    Sarker, D.
    Gillmore, R.
    Kirkwood, A.
    Hackshaw, A.
    Papadopoulou, A.
    Bell, J.
    Kayani, I.
    Toumpanakis, C.
    Grillo, F.
    Mayer, A.
    Hochhauser, D.
    Begent, R. H.
    Caplin, M. E.
    Meyer, T.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 102 (07) : 1106 - 1112
  • [4] Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
    N C Turner
    S J Strauss
    D Sarker
    R Gillmore
    A Kirkwood
    A Hackshaw
    A Papadopoulou
    J Bell
    I Kayani
    C Toumpanakis
    F Grillo
    A Mayer
    D Hochhauser
    R H Begent
    M E Caplin
    T Meyer
    [J]. British Journal of Cancer, 2010, 102 : 1106 - 1112
  • [5] Streptozocin/5-fluorouracil chemotherapy is associated with durable response in patients with advanced pancreatic neuroendocrine tumours
    Dilz, Lisa-Marie
    Denecke, Timm
    Steffen, Ingo G.
    Prasad, Vikas
    von Weikersthal, Ludwig Fischer
    Pape, Ulrich-Frank
    Wiedenmann, Bertram
    Pavel, Marianne
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (10) : 1253 - 1262
  • [6] Continuous infusion of 5-fluorouracil (5-FU) in neuroendocrine tumours (NET)
    Ducreux, M
    Baudin, E
    Thabut, D
    Rougier, P
    Tigaud, JM
    Elias, D
    Boige, V
    Schlumberger, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S213 - S213
  • [7] Effect of interferon and 5-fluorouracil on serum VEGF levels in neuroendocrine tumours
    Van Der Horst-Schrivers, Anouk N. A.
    Slot, Madeleine H. E. Bruins
    Willemse, Pax H. B.
    Kema, Ido P.
    De Vries, Elisabeth G. E.
    Wymenga, A. N. Machteld
    [J]. ACTA ONCOLOGICA, 2008, 47 (01) : 153 - 155
  • [8] Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin
    M A Gonzalez
    S Biswas
    L Clifton
    P G Corrie
    [J]. British Journal of Cancer, 2003, 89 : 455 - 456
  • [9] Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin
    Gonzalez, MA
    Biswas, S
    Clifton, L
    Corrie, PG
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (03) : 455 - 456
  • [10] Streptozocin, 5-fluorouracil/folinic acid and cisplatin (FCiSt) for advanced neuroendocrine tumours
    Sarker, D
    Williams, MT
    Buscombe, J
    Caplin, M
    Hochhauser, D
    Begent, R
    Meyer, T
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 : S65 - S65
12345